Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 26, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) and reminds investors of the August 25, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Investors can contact the law firm at no cost to learn more about recovering their losses
SAN DIEGO , June 26, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the "Class Period"), have until August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v.
6 Jun 2025 Date | | 0.01 Cons. EPS | - EPS |
5 May 2025 Date | | 0.12 Cons. EPS | 0.2 EPS |
24 Feb 2025 Date | | 0.22 Cons. EPS | 0.23 EPS |
4 Nov 2024 Date | | 0.04 Cons. EPS | 0.32 EPS |
5 Aug 2024 Date | | 0.04 Cons. EPS | 0.06 EPS |
6 Jun 2025 Date | | 0.01 Cons. EPS | - EPS |
5 May 2025 Date | | 0.12 Cons. EPS | 0.2 EPS |
24 Feb 2025 Date | | 0.22 Cons. EPS | 0.23 EPS |
4 Nov 2024 Date | | 0.04 Cons. EPS | 0.32 EPS |
5 Aug 2024 Date | | 0.04 Cons. EPS | 0.06 EPS |
Household & Personal Products Industry | Consumer Defensive Sector | Mr. Andrew Dudum CEO | NYSE Exchange | 433000106 Cusip |
US Country | 1,637 Employees | - Last Dividend | - Last Split | 13 Sep 2019 IPO Date |
Hims & Hers Health, Inc., based in San Francisco, California, operates as a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and other international locations. The company leverages its websites and mobile application to offer a variety of carefully selected health and wellness products and services, both on prescription and over-the-counter basis. Its business model focuses on providing convenient access to ongoing healthcare services, including prescription medication refills and consultations with healthcare providers, as well as a wide range of wellness products through direct sales and wholesale partnerships.